Arvinas, Inc.

Arvinas, Inc.verified

ARVN

Price:

$12.55

Market Cap:

$911.69M

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatmen...[Read more]

Industry

Biotechnology

IPO Date

2018-09-27

Stock Exchange

NASDAQ

Ticker

ARVN

The Enterprise Value as of December 2025 (TTM) for Arvinas, Inc. (ARVN) is 819.49M

According to Arvinas, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 819.49M. This represents a change of 21.88% compared to the average of 672.38M of the last 4 quarters.

Arvinas, Inc. (ARVN) Historical Enterprise Value (quarterly & annually)

How has ARVN Enterprise Value performed in the past?

The mean historical Enterprise Value of Arvinas, Inc. over the last ten years is 1.54B. The current 819.49M Enterprise Value has changed 5.22% with respect to the historical average. Over the past ten years (40 quarters), ARVN's Enterprise Value was at its highest in in the December 2021 quarter at 4.23B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

1.54B

Median

1.35B

Minimum

25.82M

Maximum

4.00B

Arvinas, Inc. (ARVN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arvinas, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.07%

Maximum Annual Enterprise Value = 4.00B

Minimum Annual Increase = -56.44%

Minimum Annual Enterprise Value = 25.82M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.29B-34.84%
20231.98B13.28%
20221.74B-56.44%
20214.00B44.36%
20202.77B105.71%
20191.35B232.56%
2018405.39M34.17%
2017302.14M1.07%

Arvinas, Inc. (ARVN) Average Enterprise Value

How has ARVN Enterprise Value performed in the past?

The current Enterprise Value of Arvinas, Inc. (ARVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.67B

5-year avg

2.36B

10-year avg

1.54B

Arvinas, Inc. (ARVN) Enterprise Value vs. Peers

How is ARVN’s Enterprise Value compared to its peers?

Arvinas, Inc.’s Enterprise Value is greater than Valneva SE (684.12M), less than ArriVent BioPharma, Inc. Common Stock (892.49M), greater than Day One Biopharmaceuticals, Inc. (815.93M), greater than Astria Therapeutics, Inc. (677.40M), greater than Replimune Group, Inc. (804.93M), greater than MeiraGTx Holdings plc (679.86M), greater than Iovance Biotherapeutics, Inc. (650.41M), less than Geron Corporation (854.51M), greater than Ginkgo Bioworks Holdings, Inc. (815.10M), less than Erasca, Inc. (888.32M),

Build a custom stock screener for Arvinas, Inc. (ARVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arvinas, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arvinas, Inc. (ARVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arvinas, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Arvinas, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Arvinas, Inc. (ARVN)?

What is the 3-year average Enterprise Value for Arvinas, Inc. (ARVN)?

What is the 5-year average Enterprise Value for Arvinas, Inc. (ARVN)?

How does the current Enterprise Value for Arvinas, Inc. (ARVN) compare to its historical average?